Add this topic to your myFT Digest for news straight to your inbox
We risk forgetting the lessons of the Covid pandemic
Cultivation of stem cells extracted from amniotic fluid will help treat congenital conditions
New Pasteur Institute head highlights risks posed by shortages of money, staff and political goodwill
GHO Capital has put contract research group FairJourney Biologics up for sale
Pharmaceutical companies scale back development in aftermath of pandemic
Research shows urgent need for policies to encourage weight loss and cut disease risk
‘Brain fog’ detectable in long and short-term cases, detailed study suggests
US biotech group’s data suggests dominance of Novo Nordisk and Eli Lilly in the anti-obesity segment could be challenged in a few years
German pharma group finds no unexpected side effects during trial, including at higher doses
I now understand why families cluster together under attack, so they can live or die as one
Baseimmune aims to predict future pathogen mutations to create jabs that will be effective for longer
Infections quadruple from last year after warnings that warming temperatures will increase cases
Head of Cancer Research UK calls for more investment and points to heavy reliance on philanthropic funding
Discovery boosts efforts to develop ‘biomarkers’ for debilitating condition and enable treatments
Best-selling Tagrisso drug slows progression of most common form of the disease at an early stage
Journalist Manoush Zomorodi explains her recent experiment in attempting to get her listeners to move more – and why it’s so hard to break our pattern of sitting
New molecule proves effective in animals against several drug-resistant bacteria
Fears condition’s range of symptoms and link to chronic diseases will have lasting impact on health systems
Large study further boosts fast-evolving efforts to predict and prevent neurogenerative diseases
Machines lack a CE certification showing they comply with EU performance and safety directives
Cancer, diabetes and heart disease patients among those facing chronic shortage of treatments
Pharma companies, while talking up pipelines, are turning to deals to boost their growth outlook
Chief executive says customers very willing to pay for Wegovy from their own pockets
Investing in new oncology drugs without building up an effective arsenal against infections is a false economy
Huge reduction in bouts of angioedema increases prospect that technique can combat a range of diseases
International Edition